Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Novo Nordisk AS(NVO) the Revenue is 12 B (-0.51%), Beat estimate;the EBIT is 5.104 B (-2.75%), Beat estimate;the EPS is 0.726 (-22.35%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
12.00B0.51%
10.94B9.32%
+1.06B8.81%
EBITExceed expectations
5.10B2.75%
4.44B15.45%
+0.67B12.70%
EPSMiss expectations
0.726122.35%
0.767417.94%
-0.04134.41%
Upcoming earnings report - Q3 FY2026
Available dateNov 4, 2026
Estimate Revenue$11.25 B
Estimate EBIT--
Estimate EPS$0.827
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf